{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T22:32:07Z","timestamp":1774391527181,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015071","name":"Laval University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jviromet.2025.115329","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:53:36Z","timestamp":1766159616000},"page":"115329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Search and prove of efficient inhibitors against papain-like protease from SARS-CoV-2"],"prefix":"10.1016","volume":"341","author":[{"given":"Wenfa","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9149-375X","authenticated-orcid":false,"given":"Sheng-Xiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2025.115329_bib1","unstructured":"Banerjee P., Kemmler E., Dunkel M., Preissner R.: ProTox 3.0: a webserver for the prediction of toxicity of chemicals, Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.jviromet.2025.115329_bib2","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1080\/07391102.2020.1766572","article-title":"Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors","volume":"39","author":"Bhardwaj","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jviromet.2025.115329_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200016","article-title":"Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS-CoV-2 Papain-Like Protease","author":"Brewitz","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jviromet.2025.115329_bib4","first-page":"433","article-title":"Quenching of protein fluorescence. I. Principles of the method. Solutions of tryptophan, tyrosine, and denaturated proteins","volume":"13","author":"Burshte\u012dn","year":"1968","journal-title":"Biofizika"},{"key":"10.1016\/j.jviromet.2025.115329_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.876212","article-title":"Inhibitors of SARS-CoV-2 PLpro","volume":"10","author":"Calleja","year":"2022","journal-title":"Front. Chem."},{"issue":"3","key":"10.1016\/j.jviromet.2025.115329_bib6","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1074\/jbc.M310875200","article-title":"Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase","volume":"279","author":"Fan","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jviromet.2025.115329_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15181-y","article-title":"Inhibitor induced conformational changes in SARS-COV-2 papain-like protease","volume":"12","author":"Ferreira","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jviromet.2025.115329_bib8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41467-020-20718-8","article-title":"The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jviromet.2025.115329_bib9","unstructured":"Governments progress on negotiations for a pandemic agreement to boost global preparedness for future emergencies (who.int) https:\/\/covid19.who.int (accessed on 2 October 2024)."},{"key":"10.1016\/j.jviromet.2025.115329_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2025.115329_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116011","article-title":"Structure-based design of SARS-CoV-2 papain-like protease inhibitors","volume":"264","author":"Jadhav","year":"2024","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.jviromet.2025.115329_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jviromet.2025.115329_bib13","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/jmv.26497","article-title":"The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics","volume":"93","author":"Kandeel","year":"2021","journal-title":"J. Med. Virol."},{"issue":"18","key":"10.1016\/j.jviromet.2025.115329_bib14","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106275","article-title":"Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2","volume":"39","author":"Klemm","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.jviromet.2025.115329_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2020.11.083","article-title":"Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors","volume":"538","author":"Li","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jviromet.2025.115329_bib16","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1021\/bi00417a023","article-title":"Interactions between Escherichia coli arginyl-tRNA synthetase and its substrates","volume":"27","author":"Lin","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.jviromet.2025.115329_bib17","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1038\/s41467-025-57905-4","article-title":"A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID","volume":"16","author":"M. Bader","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jviromet.2025.115329_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1021\/acsptsci.1c00240","article-title":"Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors","volume":"5","author":"Ma","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jviromet.2025.115329_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","article-title":"The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections","volume":"15","author":"Machhi","year":"2020","journal-title":"J. Neuroimmune Pharm."},{"key":"10.1016\/j.jviromet.2025.115329_bib20","article-title":"Discovery of SARS-CoV-2 papain-like protease (PLpro) inhibitors with efficacy in a murine infection model","volume":"10","author":"Michelle","year":"2024","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.jviromet.2025.115329_bib21","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.3390\/ijms24086970","article-title":"Study of Lipophilicity and ADME Properties of 1,9-Diazaphenothiazines with Anticancer Action","volume":"24","author":"Morak-M\u0142odawska","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jviromet.2025.115329_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12931-020-01581-z","article-title":"SARS coronavirus 2: from genome to infectome","volume":"21","author":"Rastogi","year":"2020","journal-title":"Respir. Res"},{"issue":"42","key":"10.1016\/j.jviromet.2025.115329_bib23","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1073\/pnas.0805240105","article-title":"A noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks SARS virus replication","volume":"105","author":"Ratia","year":"2008","journal-title":"Proc. Natl. Acad. Sci. (PNAS)"},{"issue":"5","key":"10.1016\/j.jviromet.2025.115329_bib24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/cells9051267","article-title":"A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping","volume":"9","author":"Romano","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jviromet.2025.115329_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.128933","article-title":"An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2","volume":"346","author":"Sharma","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.jviromet.2025.115329_bib26","article-title":"Potent, Novel SARS-CoV-2 PLpro Inhibitors Block Viral Replication in Monkey and Human Cell Cultures","author":"Shen","year":"2021","journal-title":"bioRxiv [Prepr. ]"},{"key":"10.1016\/j.jviromet.2025.115329_bib27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jviromet.2025.115329_bib28","article-title":"Structure-Activity Studies Reveal Scope for Optimisation of Ebselen-Type Inhibition of SARS-CoV-2 Main Protease","volume":"17","author":"Siegfried","year":"2022","journal-title":"ChemMedChem"},{"issue":"8","key":"10.1016\/j.jviromet.2025.115329_bib29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cbf.3753","article-title":"Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: A computational insight","volume":"40","author":"Singh","year":"2022","journal-title":"Cell Biochem Funct."},{"key":"10.1016\/j.jviromet.2025.115329_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104965","article-title":"Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach","volume":"139","author":"Singh","year":"2021","journal-title":"Comput. Biol. Med"},{"key":"10.1016\/j.jviromet.2025.115329_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104631","article-title":"Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors","volume":"136","author":"Singh","year":"2021","journal-title":"Comput. Biol. Med"},{"issue":"1","key":"10.1016\/j.jviromet.2025.115329_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ptr.7772","article-title":"Multi-target approach against SARS-CoV-2 by stone apple molecules: A master key to drug design","volume":"38","author":"Singh","year":"2024","journal-title":"Phytother. Res"},{"key":"10.1016\/j.jviromet.2025.115329_bib33","unstructured":"SwissADME:a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep."},{"key":"10.1016\/j.jviromet.2025.115329_bib34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.adm9724","article-title":"Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model","volume":"383","author":"Tan","year":"2024","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jviromet.2025.115329_bib35","first-page":"1521","article-title":"[Lead compound optimization strategy (1) --changing metabolic pathways and optimizing metabolism stability]","volume":"48","author":"Wang","year":"2013","journal-title":"Yao Xue Xue Bao"},{"issue":"1","key":"10.1016\/j.jviromet.2025.115329_bib36","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1038\/s41598-021-83229-6","article-title":"Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2","volume":"11","author":"Weglarz-Tomczak","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jviromet.2025.115329_bib37","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/jm0492002","article-title":"A Bioavailability Score. A bioavailability score","volume":"48","author":"Yvonne","year":"2005","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jviromet.2025.115329_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/v15020580","article-title":"Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2","volume":"15","author":"Zhang","year":"2023","journal-title":"Viruses"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093425002228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093425002228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:01:06Z","timestamp":1774386066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093425002228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":38,"alternative-id":["S0166093425002228"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2025.115329","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Search and prove of efficient inhibitors against papain-like protease from SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2025.115329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115329"}}